Emory Alzheimer's Disease Research Center

埃默里阿尔茨海默病研究中心

基本信息

  • 批准号:
    10212237
  • 负责人:
  • 金额:
    $ 15.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

SUMMARY/ABSTRACT: RESEARCH EDUCATION COMPONENT Alzheimer’s disease (AD) is the most common cause of dementia, affecting more than 5 million Americans. At the same time that the prevalence of AD is increasing, the number of new investigators in the US is decreasing, which may severely hamper our efforts to develop better diagnostic and treatment tools for AD and related dementias (ADRD). The goal of the Research Education Component (REC) of the Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory is to support research educational activities that complement and enhance the training of the future workforce to meet the nation’s biomedical, behavioral and clinical needs in ADRD. We will achieve this goal by identifying and supporting the research education of junior investigators and trainees from diverse backgrounds and disciplines. In Aim 1, REC leadership and mentors will work with these trainees to develop and execute tailored educational plans for new and early stage investigators to advance towards independence in conducting AD-related research. In Aim 2, we will leverage Emory’s wealth of basic and clinical scientists as well as partner Atlanta-area institutions to identify, recruit and support the research training of new/early stage investigators and trainees from diverse backgrounds and disciplines, with special emphasis on URMs, to engage in AD-related research. In Aim 3, the REC leadership and external advisory committee will rigorously monitor and evaluate the trainees, mentors, and the overall program, and implement improvements when necessary. Success of the REC will result in rolling cohorts of new investigators with a focus on diversity to lead the next generation of ADRD research.
摘要/摘要:研究性教育的组成部分

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID WEINSHENKER其他文献

DAVID WEINSHENKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID WEINSHENKER', 18)}}的其他基金

Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease
神经黑色素对阿尔茨海默氏病蓝斑神经元选择性脆弱性的贡献
  • 批准号:
    10525513
  • 财政年份:
    2022
  • 资助金额:
    $ 15.69万
  • 项目类别:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
蓝斑源甘丙肽对阿片类药物奖励和强化的贡献
  • 批准号:
    9981143
  • 财政年份:
    2020
  • 资助金额:
    $ 15.69万
  • 项目类别:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
蓝斑源甘丙肽对阿片类药物奖励和强化的贡献
  • 批准号:
    10456900
  • 财政年份:
    2020
  • 资助金额:
    $ 15.69万
  • 项目类别:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
蓝斑源甘丙肽对阿片类药物奖励和强化的贡献
  • 批准号:
    10669138
  • 财政年份:
    2020
  • 资助金额:
    $ 15.69万
  • 项目类别:
Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
  • 批准号:
    10408030
  • 财政年份:
    2020
  • 资助金额:
    $ 15.69万
  • 项目类别:
Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
  • 批准号:
    10673961
  • 财政年份:
    2020
  • 资助金额:
    $ 15.69万
  • 项目类别:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
蓝斑源甘丙肽对阿片类药物奖励和强化的贡献
  • 批准号:
    10268173
  • 财政年份:
    2020
  • 资助金额:
    $ 15.69万
  • 项目类别:
2017 Catecholamines Gordon Research Conference & Gordon Research Seminar
2017年儿茶酚胺戈登研究会议
  • 批准号:
    9321523
  • 财政年份:
    2017
  • 资助金额:
    $ 15.69万
  • 项目类别:
Neurobiology of Reward Choice
奖励选择的神经生物学
  • 批准号:
    9304986
  • 财政年份:
    2016
  • 资助金额:
    $ 15.69万
  • 项目类别:
Neurobiology of Reward Choice
奖励选择的神经生物学
  • 批准号:
    9181667
  • 财政年份:
    2016
  • 资助金额:
    $ 15.69万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.69万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了